Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs6436881 | chr2:230490251 | G/A | 1.16E-8 | 173 | 5.18 | 24.62 | 25.87 | KM Plot |
PCPG | rs6437265 | chr2:242524587 | C/T | 0.00011 | 178 | 25.87 | 27.62 | 20.28 | KM Plot |
PCPG | rs6437266 | chr2:242526914 | T/C | 4.33E-5 | 177 | 25.87 | 27.62 | 20.2 | KM Plot |
PCPG | rs6437269 | chr2:242542298 | T/C | 4.16E-5 | 177 | 25.87 | 27.27 | 20.2 | KM Plot |
PCPG | rs644305 | chr8:104009880 | G/A | 2.65E-7 | 176 | 26.27 | 19.3 | 4.03 | KM Plot |
PCPG | rs645686 | chr17:36993655 | T/C | 4.32E-6 | 174 | 25.17 | 36.33 | 24.62 | KM Plot |
PCPG | rs6469931 | chr8:121497027 | C/T | 4.11E-6 | 178 | 27.23 | 25 | 19.87 | KM Plot |
PCPG | rs6472772 | chr8:74329009 | C/T | 0.000192 | 170 | 43.47 | 27.2 | 24.7 | KM Plot |
PCPG | rs647421 | chr13:37499832 | G/A | 0.000473 | 173 | 6.37 | 24.47 | 25.47 | KM Plot |
PCPG | rs647747 | chr16:89603064 | A/G | 0.000194 | 176 | 29.57 | 25.4 | 19.53 | KM Plot |
PCPG | rs6500424 | chr16:89581589 | G/C | 0.0004 | 176 | 26.78 | 25.67 | 19.2 | KM Plot |
PCPG | rs6511040 | chr19:19671121 | C/T | 0.00036 | 178 | 25.42 | 27.23 | 20.25 | KM Plot |
PCPG | rs6533413 | chr4:78954370 | G/C | 0 | 175 | 2.93 | 25.43 | 25.47 | KM Plot |
PCPG | rs6533416 | chr4:78967611 | C/A | 0 | 177 | 2.93 | 25.43 | 25.28 | KM Plot |
PCPG | rs6533417 | chr4:78969118 | A/G | 0 | 173 | 2.93 | 25.43 | 24.93 | KM Plot |